Research progress on the kynurenine pathway in the prevention and treatment of Parkinson’s disease
AbstractParkinson’s disease (PD) is characterised by progressive death of dopamine (DA) neurons in the substantia nigra pars compacta (SNpc) and pathological accumulation of α-synuclein fibrils, as well as central nervous system inflammation. Elevated levels of central inflammatory factors in PD dis...
Main Authors: | Ping Chen, Xiaofei Geng |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2023-12-01
|
Series: | Journal of Enzyme Inhibition and Medicinal Chemistry |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/14756366.2023.2225800 |
Similar Items
-
Kynurenine Pathway in Diabetes Mellitus—Novel Pharmacological Target?
by: Kamila Kozieł, et al.
Published: (2023-01-01) -
New Perspective on Anorexia Nervosa: Tryptophan-Kynurenine Pathway Hypothesis
by: Charl Alberts, et al.
Published: (2023-02-01) -
Kynurenine Pathway Metabolites as Potential Biomarkers in Chronic Pain
by: Andrew Auyeung, et al.
Published: (2023-05-01) -
Changes in Tryptophan Metabolism on Serotonin and Kynurenine Pathways in Patients with Irritable Bowel Syndrome
by: Cezary Chojnacki, et al.
Published: (2023-03-01) -
The Role of Kynurenine and Its Metabolites in Comorbid Chronic Pain and Depression
by: Onella Athnaiel, et al.
Published: (2022-10-01)